APA-viite (7. p.)

Canil, G., Orleni, M., Posocco, B., Gagno, S., Bignucolo, A., Montico, M., . . . Toffoli, G. (2023). LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring. MDPI AG.

Chicago-viite (17. p.)

Canil, Giovanni, et al. LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring. MDPI AG, 2023.

MLA-viite (9. p.)

Canil, Giovanni, et al. LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring. MDPI AG, 2023.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.